Stanley-Laman Group’s Pediatrix Medical MD Stock Holding History

Stanley-Laman Group’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-16,260	Closed	-$1.17M	–	330
2015 Q4	$1.17M	Buy	16,260 +11,323	+229%	+$837K	0.2%	128
2015 Q3	$379K	Sell	4,937 -3,819	-44%	-$308K	0.08%	224
2015 Q2	$649K	Sell	8,756 -22,998	-72%	-$1.66M	0.12%	175
2015 Q1	$2.3M	Buy	31,754 +6,963	+28%	+$484K	0.42%	73
2014 Q4	$1.64M	Sell	24,791 -4,424	-15%	-$270K	0.31%	92
2014 Q3	$1.6M	Buy	29,215 +4,499	+18%	+$255K	0.31%	96
2014 Q2	$1.44M	Buy	24,716 +7,761	+46%	+$457K	0.26%	107
2014 Q1	$1.05M	Buy	+16,955	New	+$986K	0.18%	143

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stanley-Laman Group's MD Position: Q1 2016 in Review

Stanley-Laman Group sold out of Pediatrix Medical (MD) in Q1 2016, closing a stake of 16,260 shares — an estimated $1.17M sold.

Stanley-Laman Group first reported a position in MD in Q1 2014 and held it in 8 quarters. The position peaked at $2.3M in Q1 2015. 382 funds tracked by Wall St. Rank hold MD as of Q1 2016.

Stanley-Laman Group reported no remaining Pediatrix Medical position as of Q1 2016 after selling out during the quarter.
Stanley-Laman Group sold 16,260 Pediatrix Medical shares in Q1 2016, an estimated $1.17M.
Stanley-Laman Group first reported a position in Pediatrix Medical in Q1 2014 and held it in 8 quarters.
Stanley-Laman Group's Pediatrix Medical position peaked at $2.3M in Q1 2015.
382 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2016.

Based on Stanley-Laman Group's 13F filing for Q1 2016, filed 9 May 2016.